Cefpirome

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Cefpirome
Cefpirome.svg
Systematic (IUPAC) name
1-{[(6R,7R)-7-[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido]-2-carboxylato-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl}-5H,6H,7H-cyclopenta[b]pyridin-1-ium
Clinical data
AHFS/Drugs.com International Drug Names
Legal status ?
Identifiers
CAS number 84957-29-9 YesY
ATC code J01DE02
PubChem CID 6917674
ChemSpider 23089536 N
UNII S72Q2F09HY YesY
KEGG D07649 YesY
ChEMBL CHEMBL2106076 N
Chemical data
Formula C22H22N6O5S2 
Mol. mass 514.58 g/mol
 N (what is this?)  (verify)

Cefpirome is a fourth-generation cephalosporin. Trade names include Cefrom, Keiten, Broact, and Cefir. Cefpirome is considered highly active against Gram-negative bacteria, including Pseudomonas aeruginosa, and Gram-positive bacteria.

Spectrum of bacterial susceptibility and resistance[edit]

Bacteroides fragilis, enterococci, Pseudomonas spp. and staphylococci are resistant to cefpirome sulfate, and some Haemophilus spp. and pneumococci have developed resistance to it to varying degrees.[1]

References[edit]

  1. ^ "Cefpirome Sulfate spectrum of bacterial susceptibility and Resistance". Retrieved 10 April 2012.